1.
Serum and lipoprotein sitostanol and non-cholesterol sterols after an acute dose of plant stanol ester on its long-term consumption
by Gylling, H
European journal of nutrition, 2011-09-23, Vol.51 (5), p.615-622
2.
Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia
by AALTO-SETALA, K
Human genetics, 1989, Vol.82 (4), p.305-307
3.
4.
Biliary lipid secretion in chronic cholestatic liver disease
by Kesäniemi, Y A
Gut, 1982-11, Vol.23 (11), p.931-938
5.
Cholesterol and all-cause mortality in Honolulu
by Law, Malcolm
The Lancet (British edition), 2001-12-01, Vol.358 (9296), p.1904-1904
6.
Hepatic copper in primary biliary cirrhosis: biliary excretion and response to penicillamine treatment
by Salaspuro, M P
Gut, 1981-11, Vol.22 (11), p.901-906
7.
Pravastatin and lovastatin similarly reduce serum cholesterol and its precursor levels in familial hypercholesterolaemia
by VANHANEN, H
European journal of clinical pharmacology, 1992, Vol.42 (2), p.127-130
8.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
by Sarwar, N
The Lancet (British edition), 2010, Vol.375 (9733), p.2215-2222
9.
CT screening for lung cancer: Importance of emphysema for never smokers and smokers
by Henschke, Claudia I
Lung cancer (Amsterdam, Netherlands), 2015, Vol.88 (1), p.42-47
10.
A follow-up study found that cardiovascular risk in middle age predicted mortality and quality of life in old age
by Strandberg, Arto
Journal of clinical epidemiology, 2004, Vol.57 (4), p.415-421
11.
Regulation of low-density lipoprotein apolipoprotein B levels
by Kesäniemi, Y.Antero
The American heart journal, 1987, Vol.113 (2), p.508-513
12.
13.
Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide
by Nikkilä, E A
The Lancet (British edition), 1965-09-11, Vol.2 (7411), p.508-511
14.
Biliary Anomalies in Patients With HNF1B Diabetes
by Kettunen, Jarno L T
The journal of clinical endocrinology and metabolism, 2017-06, Vol.102 (6), p.2075-2082
15.
Gastric schwannoma: a clinicopathologic study of 51 cases and critical review of the literature
by Voltaggio, Lysandra, MD
Human pathology, 2012, Vol.43 (5), p.650-659
16.
Early Lung Cancer Action Project: overall design and findings from baseline screening
by Henschke, Claudia I
The Lancet (British edition), 1999, Vol.354 (9173), p.99-105
17.
N-Glycomic Profiling of Pheochromocytomas and Paragangliomas Separates Metastatic and Nonmetastatic Disease
by Leijon, Helena
The journal of clinical endocrinology and metabolism, 2017-11, Vol.102 (11), p.3990-4000
18.
Usefulness of Highly Sensitive Troponin as a Predictor of Short-Term Outcome in Patients With Diabetes Mellitus and Stable Coronary Artery Disease (from the ARTEMIS Study)
by Lepojärvi, E. Samuli, MD
The American journal of cardiology, 2016, Vol.117 (4), p.515-521
19.
Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma
by Inaguma, Shingo Shingo
Human pathology, 2017-08-12, Vol.71, p.1-7
20.
Screening for a cancer: thinking before rethinking
by Miettinen, O. S
European journal of epidemiology, 2010-01-01, Vol.25 (6), p.365-374
